-
Avalon Tech
2,171.00 778.15(%) -
Bharti Airtel
1,753.30 1,745.00(%) -
NSE
1,761.00 1,761.00(%) -
Molbio Diagnosti
1,368.00 1,686.50(%) -
Apollo Hospitals
8,063.00 6,680.00(%) -
Innova Captab
1,080.00 608.25(%) -
Hero Motors
152.58 156.03(%) -
Meesho
230.55 254.65(%) -
Azad Engineering
3,126.00 3,126.00(%) -
Shadowfax Technologies
278.10 98.60(%) -
Cupid
312.10 312.10(%) -
L&T Finance Ltd
264.75 234.90(%) -
Lenskart Solut.
698.00 725.00(%) -
Reliance Industries
1,196.30 1,611.20(%) -
SS Retail
761.45 888.00(%) -
Sun TV Network
664.60 664.60(%) -
Solar Industries
19,820.00 22,630.05(%) -
PB Fintech.
1,040.00 1,040.00(%) -
National High
168.00 142.00(%) -
HDFC Bank
709.70 682.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Nutraplus India Ltd Pharmaceuticals - Indian - Bulk Drugs
- Indian Private
- BSE Code : 4534.0
- ISIN : INE230G01020
-
Today’s Low
1.90 -
Today’s High
2.10
-
Open
1.90 -
Perv Close
2.00 -
52W Low
0.00 -
52W High
0.00
Key Indicators
-
P/E(TTM)
0.00
-
Mar.Cap (₹Cr.)
7.16
-
Div & Yield %
0.00
-
Book Value(₹)
-1.67
-
Debt-Equity Ratio
5.00
-
AGM Date
13-Dec-2021
-
EPS
0.00
-
P/E Ratio
0.00
Financials Ratios
-
Debt-Equity Ratio
-
-
Mar.Cap (₹Cr.)
7.16
-
RONW (%)
-
-
ROCE (%)
-
Score Board
-
Equity (₹ in Cr.)
17.05
-
BV (₹)
-1.70
-
Sales( ₹ in Cr.)
0.00
-
NP (in Cr.)
-0.34
-
NP Var(%)
-579.0
-
Div%
0.0
-
CPS (₹)
-0.10
-
EPS (₹)
-0.10
-
Traded Value (₹ in Lakhs)
7.16
-
52 Week High
0.00
-
52 Week Low
0.00
-
Price BSE
2.0
-
Price NSE
0.00
-
Market Capital( in Cr.)
7.16
-
P/C Ratio
-20.00
-
P/E Ratio
-20.00
-
Price Vs.BV
-0.10
-
30-Sep-2026( 10:13)
Corporate News - Nutra... - <p>Nutraplus India Limited inf...
-
08-Aug-2026( 04:49)
Corporate News - Nutra... - Nutraplus India Limited will h...
-
26-May-2026( 07:36)
Results - Announcements - Nutra... - Net profit of Nutraplus India...
-
20-May-2026( 05:31)
Corporate News - Nutra... - Nutraplus India will hold a me...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.02 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.02 |
| Other Income | 0.16 | 0.00 | 0.00 | 0.00 | 0.62 | 12.59 |
| Stock Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | -1.74 | 0.00 |
| Total Income | 0.16 | 0.00 | 0.00 | 0.00 | -1.02 | 12.61 |
| EXPENDITURE : | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 1.82 | 0.00 |
| Power and Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Employee Cost | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.07 |
| Other Manufacturing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling and Administration Expenses | 0.48 | 0.03 | 0.04 | 0.10 | 0.02 | 0.11 |
| Miscellaneous Expenses | 0.00 | 0.00 | 0.00 | 0.01 | 0.04 | 36.16 |
| Employee Benefit Expenses | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.07 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | -0.12 | 0.00 |
| Total Expenses | 0.50 | 0.05 | 0.06 | 0.13 | 2.02 | 36.33 |
| Operating Profit | -0.34 | -0.05 | -0.06 | -0.13 | -3.03 | -23.72 |
| Interest | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.80 |
| Gross Profit | -0.34 | -0.05 | -0.06 | -0.16 | -3.03 | -24.52 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit Before Tax | -0.34 | -0.05 | -0.06 | -0.16 | -3.03 | -24.52 |
| Current Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Net Profit | -0.34 | -0.05 | -0.06 | -0.16 | -3.03 | -24.52 |
| Extraordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -23.45 |
| Adjusted Net Profit | -0.34 | -0.05 | -0.06 | -0.16 | -3.03 | -1.07 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance brought forward | -62.57 | -62.52 | -62.45 | -62.31 | -59.28 | -34.76 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | -62.91 | -62.57 | -62.52 | -62.47 | -62.31 | -59.28 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | -0.10 | -0.01 | -0.02 | -0.05 | -0.89 | -7.19 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - | -7.19 |
| Book Value | -1.67 | -1.57 | -1.55 | -1.54 | -1.49 | -0.60 |
| Book Value(Adj)-Unit Curr | - | - | - | - | - | -0.60 |
